Hurley Capital »

Sarepta Therapeutics shares owned by Hurley Capital

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Hurley Capital from 13F filings

Historical chart of Hurley Capital investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Hurley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Hurley Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $76k 600 126.29

More positions owned by Hurley Capital

Vanguard Value ETF Uit Exchange Traded (VTV)
Vanguard Russell Uit Exchange Traded (VONG)
Vanguard Govt Bond ETF Uit Exchange Traded (VGIT)
Ishares Ibonds 2025 Term Uit Exchange Traded (IBHE)
Sprott Physical Silver TRUST Trust Unit Common Stock (PSLV)
Vanguard S&P 500 ETF Uit Exchange Traded
Enterprise Prd Prtnrs Common Stock (EPD)
Technology Select Sector Uit Exchange Traded (XLK)
Ishares Ibnd 2026 Trm Hg Uit Exchange Traded (IBHF)
Schwab International Uit Exchange Traded (SCHF)
Alphabet Inc Class A Common Stock (GOOGL)
Morgan Stanley Common Stock (MS)
Schwab US Large Cap Etf Uit Exchange Traded (SCHX)
Schwab US Large Cap Uit Exchange Traded (SCHG)
Blackstone Group Common Stock

View all positions for Hurley Capital

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
Capital Research and Management Company - Division 3
Henderson Group
State Street Corporation
Farallon Capital Management
venBio Select Advisor
Bank of New York Mellon
Wellington Management Company
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
UBS Group
Groupama Asset Managment

View all funds holding Sarepta Therapeutics